A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Are currently enrolled and active in the originator study, LOXO-BTK-18001. A participant is considered active in the study if they are:
* receiving study intervention
* in the short-term follow-up period, or
* in the long-term follow-up period
You may not be if
Were a participant in the Phase 1b cohort of Study LOXO-BTK-18001
Clareo Health | A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
